Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.
NCT03983096
·
clinicaltrials.gov ↗
COMPLETED
Status
1213
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Collaborators
[object Object]